首页 > 最新文献

Frontiers in ophthalmology最新文献

英文 中文
Intramuscular orbital schwannoma: case report and review of the literature. 眼眶肌内神经鞘瘤一例报告及文献复习。
IF 0.9 Pub Date : 2025-05-23 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1586465
Hammam A Alotaibi, Firas Madani, Rawan N Althaqib, Hamad M AlSulaiman

Orbital schwannomas are benign tumors that arise from Schwann cells in the peripheral nerves in the orbit. They typically present after the second decade of life given their slow growth and rarely before then. Diagnosis is based on clinical course and specific imaging modalities; however, the definitive diagnosis is by lesion biopsy. Surgical removal is typically curative. Herein we present the case of an 8-year-old boy with proptosis and diplopia where he exhibited the clinical findings of an orbital mass, however, the characteristic picture of orbital schwannoma was observed on imaging yet found within the inferior rectus muscle, a rare finding indeed.

眼眶神经鞘瘤是由眼眶周围神经的雪旺细胞引起的良性肿瘤。由于生长缓慢,它们通常在生命的第二个十年之后出现,很少在此之前出现。诊断是基于临床过程和特定的成像模式;然而,明确的诊断是通过病变活检。手术切除是典型的治疗方法。在此,我们报告一例8岁男孩的突出和复视,他的临床表现为眼眶肿块,然而,在影像学上观察到眼眶神经鞘瘤的特征,但在下直肌内发现,确实是罕见的发现。
{"title":"Intramuscular orbital schwannoma: case report and review of the literature.","authors":"Hammam A Alotaibi, Firas Madani, Rawan N Althaqib, Hamad M AlSulaiman","doi":"10.3389/fopht.2025.1586465","DOIUrl":"10.3389/fopht.2025.1586465","url":null,"abstract":"<p><p>Orbital schwannomas are benign tumors that arise from Schwann cells in the peripheral nerves in the orbit. They typically present after the second decade of life given their slow growth and rarely before then. Diagnosis is based on clinical course and specific imaging modalities; however, the definitive diagnosis is by lesion biopsy. Surgical removal is typically curative. Herein we present the case of an 8-year-old boy with proptosis and diplopia where he exhibited the clinical findings of an orbital mass, however, the characteristic picture of orbital schwannoma was observed on imaging yet found within the inferior rectus muscle, a rare finding indeed.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1586465"},"PeriodicalIF":0.9,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Eyelid reconstruction using intact fish skin xenograft following periorbital necrotizing fasciitis. 病例报告:眼眶周围坏死性筋膜炎后用完整鱼皮异种移植重建眼睑。
Pub Date : 2025-05-22 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1589771
Molly Shott, Diane Wang, John Nguyen

Periorbital necrotizing fasciitis (NF) is a rare, vision-threatening soft tissue infection that requires rapid antimicrobial treatments to minimize devastating soft tissue destruction, and debridement of affected tissue results in extensive defects requiring various techniques of reconstruction. We herein describe a case of a 58-year-old male with periorbital NF who underwent eyelid repair with intact fish skin grafts. To our knowledge, this is the first case report of fish skin grafts being used in eyelid wound management after periorbital NF.

眶周坏死性筋膜炎(NF)是一种罕见的、威胁视力的软组织感染,需要快速抗菌治疗以尽量减少破坏性的软组织破坏,并且受影响组织的清创导致广泛的缺陷,需要各种技术的重建。我们在此报告一例58岁男性眼眶周围NF患者,接受完整鱼皮移植修复眼睑。据我们所知,这是第一例鱼皮移植用于眼眶周围NF术后眼睑伤口处理的报告。
{"title":"Case Report: Eyelid reconstruction using intact fish skin xenograft following periorbital necrotizing fasciitis.","authors":"Molly Shott, Diane Wang, John Nguyen","doi":"10.3389/fopht.2025.1589771","DOIUrl":"10.3389/fopht.2025.1589771","url":null,"abstract":"<p><p>Periorbital necrotizing fasciitis (NF) is a rare, vision-threatening soft tissue infection that requires rapid antimicrobial treatments to minimize devastating soft tissue destruction, and debridement of affected tissue results in extensive defects requiring various techniques of reconstruction. We herein describe a case of a 58-year-old male with periorbital NF who underwent eyelid repair with intact fish skin grafts. To our knowledge, this is the first case report of fish skin grafts being used in eyelid wound management after periorbital NF.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1589771"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative analysis of idiopathic epiretinal membrane traction: an updated version of the relaxation index. 特发性视网膜前膜牵引的定量分析:松弛指数的更新版本。
Pub Date : 2025-05-22 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1528766
Davide Allegrini, Raffaele Raimondi, Giovanni Montesano, Marco Caruso, Giovanna Lionetti, Adriano Carnevali, Tania Sorrentino, Vincenzo Scorcia, Mario R Romano

Purpose: The aim of this work was to track tangential traction of idiopathic epiretinal membrane from an initial assessment to the immediate post-operative phase using an enhanced version of the relaxation index (RI).

Methods: A retrospective analysis was conducted on 9 patients who underwent peeling surgery for idiopathic, symptomatic, and progressive epiretinal membrane. The RI assesses the displacement of vascular crossings in time from a fixed point, which is the retinal pigmented epithelium. This updated iteration integrates infrared images paired with OCT scans instead of OCTA.

Results: The study encompassed three timepoints: T1 (initial appointment), T2 (1 week pre-surgery), and Post (1 month post-surgery). T1 was 12± 9 months prior to surgery. A statistically significant difference (p<0.001) in RI was observed across all three timepoints; however, there was no significant correlation between RI and visual acuity (p>0.05).

Conclusion: The RI emerges as a comprehensive and direct parameter for objectively assessing and monitoring tangential traction in three dimensions across an extensive area of the posterior pole. Further streamlining of the process is necessary to integrate this feature into clinical practice effectively.

目的:本研究的目的是使用增强版的松弛指数(RI)跟踪特发性视网膜前膜从初始评估到立即术后阶段的切向牵引。方法:回顾性分析9例特发性、症状性和进行性视网膜前膜剥离手术患者的临床资料。RI从一个固定点(即视网膜色素上皮)及时评估血管交叉的位移。这个更新的迭代集成了红外图像与OCT扫描配对,而不是OCTA。结果:研究包括三个时间点:T1(初次预约)、T2(术前1周)和术后(术后1个月)。T1为术前12±9个月。差异有统计学意义(p0.05)。结论:RI是客观评估和监测后极广泛区域切向牵引力的三维全面直接参数。为了将这一特点有效地融入临床实践,进一步简化这一过程是必要的。
{"title":"Quantitative analysis of idiopathic epiretinal membrane traction: an updated version of the relaxation index.","authors":"Davide Allegrini, Raffaele Raimondi, Giovanni Montesano, Marco Caruso, Giovanna Lionetti, Adriano Carnevali, Tania Sorrentino, Vincenzo Scorcia, Mario R Romano","doi":"10.3389/fopht.2025.1528766","DOIUrl":"10.3389/fopht.2025.1528766","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this work was to track tangential traction of idiopathic epiretinal membrane from an initial assessment to the immediate post-operative phase using an enhanced version of the relaxation index (RI).</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 9 patients who underwent peeling surgery for idiopathic, symptomatic, and progressive epiretinal membrane. The RI assesses the displacement of vascular crossings in time from a fixed point, which is the retinal pigmented epithelium. This updated iteration integrates infrared images paired with OCT scans instead of OCTA.</p><p><strong>Results: </strong>The study encompassed three timepoints: T1 (initial appointment), T2 (1 week pre-surgery), and Post (1 month post-surgery). T1 was 12± 9 months prior to surgery. A statistically significant difference (p<0.001) in RI was observed across all three timepoints; however, there was no significant correlation between RI and visual acuity (p>0.05).</p><p><strong>Conclusion: </strong>The RI emerges as a comprehensive and direct parameter for objectively assessing and monitoring tangential traction in three dimensions across an extensive area of the posterior pole. Further streamlining of the process is necessary to integrate this feature into clinical practice effectively.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1528766"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orbital inflammatory disease in a primarily black patient population. 眼眶炎症性疾病主要发生在黑人患者人群中。
Pub Date : 2025-05-22 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1576929
Gabriel Kabarriti, Ali Elsayed, Giannis A Moustafa, Nickisa Hodgson

Purpose: The purpose of this study is to characterize orbital inflammatory disease (OID) in a primarily Black patient population, examining their demographics, presentations, workup, treatment, and outcome.

Methods: A retrospective study was performed from January 2005 to June 2022 at two academic institutions in Brooklyn, NY. Patients included met criteria for one of the following OID conditions: non-specific orbital inflammation; nonbacterial dacryoadenitis; Tolosa-Hunt; orbital myositis; definite, possible, or probable IgG4-related ophthalmic disease; and sclerosing orbital inflammation. Data reviewed included orbital inflammatory labs, imaging, pathology, and treatment. Treatment was considered successful if a patient had complete resolution of symptoms.

Results: Thirty-nine patients met criteria for this study. 35.9% were diagnosed with dacryoadenitis, 28.2% with NSOI, 12.8% with myositis, 5.1% with possible IgG-ROD, 7.7% with probable IgG4-ROD, 7.7% with Tolosa Hunt, and 2.6% with sclerosing OI. 91% were started on steroids; 12.8% required transition to steroid-sparing therapy. 85% had a successful outcome with a resolution of symptoms.

Conclusions: This study characterizes OID in a Black patient population and compares it to prior studies done on OID. Research on underrepresented patient populations is needed to understand differences in disease presentation and improve patient outcomes.

目的:本研究的目的是在主要的黑人患者人群中描述眼窝炎症性疾病(OID),检查他们的人口统计学、表现、随访、治疗和结果。方法:2005年1月至2022年6月在纽约布鲁克林的两所学术机构进行回顾性研究。纳入的患者符合以下情况之一的标准:非特异性眼窝炎症;无菌泪腺炎;Tolosa-Hunt;轨道肌炎;明确的、可能的或可能的与igg4相关的眼部疾病;以及硬化性眼窝炎症。回顾的资料包括眼眶炎症实验室、影像学、病理和治疗。如果患者症状完全缓解,则认为治疗成功。结果:39例患者符合本研究标准。35.9%诊断为泪腺炎,28.2%诊断为NSOI, 12.8%诊断为肌炎,5.1%诊断为IgG-ROD, 7.7%诊断为IgG4-ROD, 7.7%诊断为Tolosa Hunt, 2.6%诊断为硬化性成骨不全。91%的患者开始使用类固醇;12.8%需要过渡到保留类固醇治疗。85%的患者取得了症状缓解的成功结果。结论:本研究描述了黑人患者的OID特征,并将其与先前的OID研究进行了比较。需要对代表性不足的患者群体进行研究,以了解疾病表现的差异并改善患者的预后。
{"title":"Orbital inflammatory disease in a primarily black patient population.","authors":"Gabriel Kabarriti, Ali Elsayed, Giannis A Moustafa, Nickisa Hodgson","doi":"10.3389/fopht.2025.1576929","DOIUrl":"10.3389/fopht.2025.1576929","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study is to characterize orbital inflammatory disease (OID) in a primarily Black patient population, examining their demographics, presentations, workup, treatment, and outcome.</p><p><strong>Methods: </strong>A retrospective study was performed from January 2005 to June 2022 at two academic institutions in Brooklyn, NY. Patients included met criteria for one of the following OID conditions: non-specific orbital inflammation; nonbacterial dacryoadenitis; Tolosa-Hunt; orbital myositis; definite, possible, or probable IgG4-related ophthalmic disease; and sclerosing orbital inflammation. Data reviewed included orbital inflammatory labs, imaging, pathology, and treatment. Treatment was considered successful if a patient had complete resolution of symptoms.</p><p><strong>Results: </strong>Thirty-nine patients met criteria for this study. 35.9% were diagnosed with dacryoadenitis, 28.2% with NSOI, 12.8% with myositis, 5.1% with possible IgG-ROD, 7.7% with probable IgG4-ROD, 7.7% with Tolosa Hunt, and 2.6% with sclerosing OI. 91% were started on steroids; 12.8% required transition to steroid-sparing therapy. 85% had a successful outcome with a resolution of symptoms.</p><p><strong>Conclusions: </strong>This study characterizes OID in a Black patient population and compares it to prior studies done on OID. Research on underrepresented patient populations is needed to understand differences in disease presentation and improve patient outcomes.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1576929"},"PeriodicalIF":0.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12137059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low anterior chamber volume as a risk factor in non-arteritic anterior ischemic optic neuropathy. 低前房容积作为非动脉性前缺血性视神经病变的危险因素。
Pub Date : 2025-05-20 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1554279
Durgul Acan, Beyza Betul Cakar, Eyyup Karahan

Purpose: This study aimed to compare the anterior chamber depth (ACD), anterior chamber volume (ACV), and iridocorneal angle (ICA) of the eyes of patients with non-arteritic anterior ischemic optic neuropathy (NAION) and normal eyes.

Methods: In this cross-sectional study, 28 patients with NAION who were admitted to our institution were examined. Central corneal thickness (CCT), ACV, ACD, and ICA of all eyes were measured using corneal topography (Sirius, CSO, Italy). Axial lengths (ALs) were measured using an IOL-Master 500 (Carl Zeiss, Meditec). The eyes of these patients were compared with the eyes of 29 healthy individuals of similar age and gender.

Results: The mean ALs of the eyes with NAION and those in the control group were not statistically different, measuring 22.95 ± 0.68 mm and 23.13 ± 0.80mm, respectively (p=0.651). While the average ACV was 137.93 ± 41.01 mm3 in the control group, it was significantly lower at 117.86 ± 22.23 mm3 in the patients with NAION (p=0.038). The mean ACD, ICA, and CCT values in the control and study groups were not statistically different, with 2.82 ± 0.57 mm and 2.64 ± 0.31 mm, 41.62 ± 6.99° and 40.14 ± 7.04°, and 542.48 ± 19.39µm and 544.68 ± 31.26 µm, respectively (p1 = 0.236, p2 = 0.693, and p3 = 0.959). No statistical differences were found between the eyes with NAION and their fellow eyes in terms of AL, CCT, ACD, ACV, and ICA (p>0.05).

Conclusion: Differences in anterior segment morphology were observed in eyes with NAION compared to healthy eyes. Decreased ACV may be a risk factor for NAION.

目的:比较非动脉性前缺血性视神经病变(NAION)患者与正常人眼睛的前房深度(ACD)、前房容积(ACV)和虹膜角膜角(ICA)。方法:在本横断面研究中,对我院收治的28例NAION患者进行了检查。采用角膜地形图(Sirius, CSO, Italy)测量所有眼的角膜中央厚度(CCT)、ACV、ACD和ICA。使用IOL-Master 500 (Carl Zeiss, Meditec)测量眼轴长。将这些患者的眼睛与29名年龄和性别相近的健康人的眼睛进行比较。结果:NAION组与对照组的平均ALs值差异无统计学意义,分别为22.95±0.68 mm和23.13±0.80mm (p=0.651)。对照组ACV均值为137.93±41.01 mm3,而NAION组ACV均值为117.86±22.23 mm3,差异有统计学意义(p=0.038)。对照组和研究组的ACD、ICA、CCT平均值分别为2.82±0.57 mm和2.64±0.31 mm, 41.62±6.99°和40.14±7.04°,542.48±19.39µm和544.68±31.26µm,差异无统计学意义(p1 = 0.236, p2 = 0.693, p3 = 0.959)。在AL、CCT、ACD、ACV、ICA方面,NAION组与正常组比较无统计学差异(p < 0.05)。结论:与健康眼相比,NAION眼前节形态存在差异。ACV降低可能是NAION的危险因素。
{"title":"Low anterior chamber volume as a risk factor in non-arteritic anterior ischemic optic neuropathy.","authors":"Durgul Acan, Beyza Betul Cakar, Eyyup Karahan","doi":"10.3389/fopht.2025.1554279","DOIUrl":"10.3389/fopht.2025.1554279","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare the anterior chamber depth (ACD), anterior chamber volume (ACV), and iridocorneal angle (ICA) of the eyes of patients with non-arteritic anterior ischemic optic neuropathy (NAION) and normal eyes.</p><p><strong>Methods: </strong>In this cross-sectional study, 28 patients with NAION who were admitted to our institution were examined. Central corneal thickness (CCT), ACV, ACD, and ICA of all eyes were measured using corneal topography (Sirius, CSO, Italy). Axial lengths (ALs) were measured using an IOL-Master 500 (Carl Zeiss, Meditec). The eyes of these patients were compared with the eyes of 29 healthy individuals of similar age and gender.</p><p><strong>Results: </strong>The mean ALs of the eyes with NAION and those in the control group were not statistically different, measuring 22.95 ± 0.68 mm and 23.13 ± 0.80mm, respectively (p=0.651). While the average ACV was 137.93 ± 41.01 mm<sup>3</sup> in the control group, it was significantly lower at 117.86 ± 22.23 mm<sup>3</sup> in the patients with NAION (p=0.038). The mean ACD, ICA, and CCT values in the control and study groups were not statistically different, with 2.82 ± 0.57 mm and 2.64 ± 0.31 mm, 41.62 ± 6.99° and 40.14 ± 7.04°, and 542.48 ± 19.39µm and 544.68 ± 31.26 µm, respectively (p1 = 0.236, p2 = 0.693, and p3 = 0.959). No statistical differences were found between the eyes with NAION and their fellow eyes in terms of AL, CCT, ACD, ACV, and ICA (p>0.05).</p><p><strong>Conclusion: </strong>Differences in anterior segment morphology were observed in eyes with NAION compared to healthy eyes. Decreased ACV may be a risk factor for NAION.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1554279"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129766/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease. 协同人工智能住院治疗方法在青光眼和视网膜疾病的三级眼科护理中实现了卓越的诊断准确性。
IF 0.9 Pub Date : 2025-05-19 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1581212
Dalia Camacho-García-Formentí, Gabriela Baylón-Vázquez, Karen Arriozola-Rodríguez, Enrique Avalos-Ramirez, Curt Hartleben-Matkin, Hugo Valdez-Flores, Damaris Hodelin-Fuentes, Alejandro Noriega

Introduction: Artificial intelligence (AI) shows promise in ophthalmology, but its potential in tertiary care settings in Latin America remains understudied. We present a Mexican AI-powered screening tool and evaluate it against first-year ophthalmology residents in a tertiary care setting in Mexico City.

Methods: We analyzed data from 435 adult patients undergoing their first ophthalmic evaluation using an AI-based platform and first-year ophthalmology residents. The platform employs an Inception V3-based multi-output classification model with 512 × 512 input resolution to capture small lesions when detecting retinal disease. To evaluate glaucoma suspects, the system uses U-Net models that segment the optic disc and cup to calculate cup-to-disc ratio (CDR) from their vertical heights. The AI and resident evaluations were compared with expert annotations for retinal disease, CDR measurements, and glaucoma suspect classification. In addition, we evaluated a synergistic approach combining AI and resident assessments.

Results: For glaucoma suspect classification, AI outperformed residents in accuracy (88.6% vs. 82.9%, p = 0.016), sensitivity (63.0% vs. 50.0%, p = 0.116), and specificity (94.5% vs. 90.5%, p = 0.062). The synergistic approach achieved a higher sensitivity (80.4%) than ophthalmic residents alone or AI alone (p < 0.001). AI's CDR estimates showed lower mean absolute error (0.056 vs. 0.105, p < 0.001) and higher correlation with expert measurements (r = 0.728 vs. r = 0.538). In the retinal disease assessment, AI demonstrated higher sensitivity (90.1% vs. 63.0% for medium/high risk, p < 0.001) and specificity (95.8% vs. 90.4%, p < 0.001). Furthermore, differences between AI and residents were statistically significant across all metrics. The synergistic approach achieved the highest sensitivity for retinal disease (92.6% for medium/high risk, 100% for high risk).

Discussion: AI outperformed first-year residents in key ophthalmic assessments. The synergistic use of AI and resident assessments showed potential for optimizing diagnostic accuracy, highlighting the value of AI as a supportive tool in ophthalmic practice, especially for early career clinicians.

导言:人工智能(AI)在眼科领域显示出前景,但其在拉丁美洲三级保健机构中的潜力仍未得到充分研究。我们介绍了一种墨西哥人工智能筛查工具,并对墨西哥城三级医疗机构的一年级眼科住院医生进行了评估。方法:我们分析了使用人工智能平台进行首次眼科评估的435名成年患者和第一年眼科住院医师的数据。该平台采用基于Inception v3的多输出分类模型,输入分辨率为512 × 512,在检测视网膜疾病时捕获小病变。为了评估青光眼的可能性,该系统使用U-Net模型,将视盘和视杯分割,从它们的垂直高度计算杯盘比(CDR)。将人工智能和住院医师评估与专家对视网膜疾病、CDR测量和青光眼可疑分类的注释进行比较。此外,我们评估了结合人工智能和居民评估的协同方法。结果:人工智能对青光眼可疑分类的准确率(88.6%比82.9%,p = 0.016)、灵敏度(63.0%比50.0%,p = 0.116)和特异性(94.5%比90.5%,p = 0.062)均优于住院医师。协同方法的灵敏度(80.4%)高于眼科住院医师单独或人工智能单独(p < 0.001)。AI的CDR估计显示出较低的平均绝对误差(0.056 vs. 0.105, p 0.001),与专家测量值的相关性较高(r = 0.728 vs. r = 0.538)。在视网膜疾病评估中,人工智能显示出更高的灵敏度(90.1%对63.0%,p 0.001)和特异性(95.8%对90.4%,p 0.001)。此外,人工智能和居民之间的差异在所有指标上都具有统计学意义。协同方法对视网膜疾病的敏感性最高(中高风险为92.6%,高风险为100%)。讨论:AI在关键眼科评估中优于第一年住院医师。人工智能和住院医师评估的协同使用显示出优化诊断准确性的潜力,突出了人工智能作为眼科实践支持工具的价值,特别是对早期职业临床医生。
{"title":"Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease.","authors":"Dalia Camacho-García-Formentí, Gabriela Baylón-Vázquez, Karen Arriozola-Rodríguez, Enrique Avalos-Ramirez, Curt Hartleben-Matkin, Hugo Valdez-Flores, Damaris Hodelin-Fuentes, Alejandro Noriega","doi":"10.3389/fopht.2025.1581212","DOIUrl":"10.3389/fopht.2025.1581212","url":null,"abstract":"<p><strong>Introduction: </strong>Artificial intelligence (AI) shows promise in ophthalmology, but its potential in tertiary care settings in Latin America remains understudied. We present a Mexican AI-powered screening tool and evaluate it against first-year ophthalmology residents in a tertiary care setting in Mexico City.</p><p><strong>Methods: </strong>We analyzed data from 435 adult patients undergoing their first ophthalmic evaluation using an AI-based platform and first-year ophthalmology residents. The platform employs an Inception V3-based multi-output classification model with 512 × 512 input resolution to capture small lesions when detecting retinal disease. To evaluate glaucoma suspects, the system uses U-Net models that segment the optic disc and cup to calculate cup-to-disc ratio (CDR) from their vertical heights. The AI and resident evaluations were compared with expert annotations for retinal disease, CDR measurements, and glaucoma suspect classification. In addition, we evaluated a synergistic approach combining AI and resident assessments.</p><p><strong>Results: </strong>For glaucoma suspect classification, AI outperformed residents in accuracy (88.6% vs. 82.9%, <i>p</i> = 0.016), sensitivity (63.0% vs. 50.0%, <i>p</i> = 0.116), and specificity (94.5% vs. 90.5%, <i>p</i> = 0.062). The synergistic approach achieved a higher sensitivity (80.4%) than ophthalmic residents alone or AI alone (<i>p <</i> 0.001). AI's CDR estimates showed lower mean absolute error (0.056 vs. 0.105, <i>p <</i> 0.001) and higher correlation with expert measurements (<i>r</i> = 0.728 vs. <i>r</i> = 0.538). In the retinal disease assessment, AI demonstrated higher sensitivity (90.1% vs. 63.0% for medium/high risk, <i>p <</i> 0.001) and specificity (95.8% vs. 90.4%, <i>p <</i> 0.001). Furthermore, differences between AI and residents were statistically significant across all metrics. The synergistic approach achieved the highest sensitivity for retinal disease (92.6% for medium/high risk, 100% for high risk).</p><p><strong>Discussion: </strong>AI outperformed first-year residents in key ophthalmic assessments. The synergistic use of AI and resident assessments showed potential for optimizing diagnostic accuracy, highlighting the value of AI as a supportive tool in ophthalmic practice, especially for early career clinicians.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1581212"},"PeriodicalIF":0.9,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12127187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144210406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"REACH'' for troubleshooting peripheral defocus myopia control spectacles. “REACH”用于排除周边离焦近视控制眼镜。
Pub Date : 2025-05-15 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1583599
Sujit Shah, Gautam Motwani, Pavan K Verkicharla
{"title":"\"REACH'' for troubleshooting peripheral defocus myopia control spectacles.","authors":"Sujit Shah, Gautam Motwani, Pavan K Verkicharla","doi":"10.3389/fopht.2025.1583599","DOIUrl":"10.3389/fopht.2025.1583599","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1583599"},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12119269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144183685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Women in lens and cataract. 社论:戴晶状体和白内障的女性。
Pub Date : 2025-05-09 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1616466
Catherine Cheng, Barbara Pierscionek
{"title":"Editorial: Women in lens and cataract.","authors":"Catherine Cheng, Barbara Pierscionek","doi":"10.3389/fopht.2025.1616466","DOIUrl":"https://doi.org/10.3389/fopht.2025.1616466","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1616466"},"PeriodicalIF":0.0,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12098023/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144144723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: observational cohort study. 口服心得安治疗婴幼儿眼附件血管瘤的实际疗效和安全性:观察队列研究。
Pub Date : 2025-05-05 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1493171
Stefano Malvindi, Elena Sammarco, Andrea Elefante, Vittoria Lanni, Domenico Cicala, Francesco Esposito, Ciro Picardi, Adriana Iuliano, Dana Cohen, Giuseppe Mariniello, Antonella D'Aponte, Ciro Costagliola, Francesco Briganti, Diego Strianese

Objective: To assess the effectiveness and safety of oral propranolol for the treatment of ocular adnexal infantile hemangiomas.

Patients and methods: retrospective observational cohort study. Propranolol was administered at an initial oral dose of 1 mg/kg and subsequently increased to 2 mg/kg for 1 year. Outcomes were evaluated by comparing pre- and post-treatment clinical findings, contrast-enhanced ultrasound (CEUS) findings and/or orbital magnetic resonance imaging findings from baseline to 3, 6, 9, 12, 24, and 48 weeks. Regression was graded as follows: satisfactory when 90% and above of the baseline lesion volume and extension decreased, acceptable when 50 to 90%, mediocre when 30 to 50%, poor less than 30%.

Results: Twenty-four patients were included in this study. The mean age at presentation was 4 ± 1 week. Sixteen (71%) patients were females and 7 (29%) were males. The mean follow-up duration was 18 ± 3 months. Therapy was started for of 23/24 patients at 5 weeks old, of 1/24 started at 9 weeks of age. The median age was 5,16 weeks. Sixteen patients (66%) had satisfactory resolution between 3 and 6 weeks, 5 (20%) after 9 weeks, and 3 (12%) after 12 weeks. One patient (5%) had a mediocre response after 24 weeks. One patient withdrew from therapy because of hypoglycemia, which was successfully managed as an outpatient. No significant adverse reactions, such as bradycardia, hypotension, bronchospasm, or congestive heart failure, were detected in this cohort.

Conclusion: This study indicates that the real-life use of oral propranolol for infantile hemangioma yields a high success rate with a lower morbidity than previously reported, particularly when managed by a proficient and multidisciplinary team.

目的:评价口服心得安治疗婴幼儿眼附件血管瘤的有效性和安全性。患者和方法:回顾性观察队列研究。心得安的初始口服剂量为1mg /kg,随后增加至2mg /kg,持续1年。通过比较治疗前和治疗后的临床表现、超声造影(CEUS)结果和/或眼眶磁共振成像结果,从基线到3、6、9、12、24和48周来评估结果。退化程度分级如下:90%及以上基线病变体积和扩展减小,满意;50%至90%,可接受;30%至50%,一般;30%以下,差。结果:24例患者纳入本研究。平均发病年龄为4±1周。女性16例(71%),男性7例(29%)。平均随访时间18±3个月。23/24的患者在5周龄时开始治疗,1/24的患者在9周龄时开始治疗。中位年龄为5.16周。16例患者(66%)在3 ~ 6周内获得满意的缓解,9周后5例(20%),12周后3例(12%)。1例患者(5%)在24周后反应一般。一名患者因低血糖而退出治疗,作为门诊成功治疗。在这个队列中没有发现明显的不良反应,如心动过缓、低血压、支气管痉挛或充血性心力衰竭。结论:本研究表明,实际使用口服心得安治疗婴儿血管瘤的成功率高,发病率低于先前报道,特别是在熟练和多学科团队的管理下。
{"title":"Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: observational cohort study.","authors":"Stefano Malvindi, Elena Sammarco, Andrea Elefante, Vittoria Lanni, Domenico Cicala, Francesco Esposito, Ciro Picardi, Adriana Iuliano, Dana Cohen, Giuseppe Mariniello, Antonella D'Aponte, Ciro Costagliola, Francesco Briganti, Diego Strianese","doi":"10.3389/fopht.2025.1493171","DOIUrl":"10.3389/fopht.2025.1493171","url":null,"abstract":"<p><strong>Objective: </strong>To assess the effectiveness and safety of oral propranolol for the treatment of ocular adnexal infantile hemangiomas.</p><p><strong>Patients and methods: </strong>retrospective observational cohort study. Propranolol was administered at an initial oral dose of 1 mg/kg and subsequently increased to 2 mg/kg for 1 year. Outcomes were evaluated by comparing pre- and post-treatment clinical findings, contrast-enhanced ultrasound (CEUS) findings and/or orbital magnetic resonance imaging findings from baseline to 3, 6, 9, 12, 24, and 48 weeks. Regression was graded as follows: satisfactory when 90% and above of the baseline lesion volume and extension decreased, acceptable when 50 to 90%, mediocre when 30 to 50%, poor less than 30%.</p><p><strong>Results: </strong>Twenty-four patients were included in this study. The mean age at presentation was 4 ± 1 week. Sixteen (71%) patients were females and 7 (29%) were males. The mean follow-up duration was 18 ± 3 months. Therapy was started for of 23/24 patients at 5 weeks old, of 1/24 started at 9 weeks of age. The median age was 5,16 weeks. Sixteen patients (66%) had satisfactory resolution between 3 and 6 weeks, 5 (20%) after 9 weeks, and 3 (12%) after 12 weeks. One patient (5%) had a mediocre response after 24 weeks. One patient withdrew from therapy because of hypoglycemia, which was successfully managed as an outpatient. No significant adverse reactions, such as bradycardia, hypotension, bronchospasm, or congestive heart failure, were detected in this cohort.</p><p><strong>Conclusion: </strong>This study indicates that the real-life use of oral propranolol for infantile hemangioma yields a high success rate with a lower morbidity than previously reported, particularly when managed by a proficient and multidisciplinary team.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1493171"},"PeriodicalIF":0.0,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144103201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolated third cranial nerve palsy as the presenting sign of tuberculum sellae meningioma: a case report. 孤立性第三脑神经麻痹为鞍结节脑膜瘤的表现:1例报告。
Pub Date : 2025-04-30 eCollection Date: 2025-01-01 DOI: 10.3389/fopht.2025.1525183
Azizah Alotaibi, Fay Althunayyan, Shuroq Alshehri, Hosam Al-Jehani

Tuberculum sellae meningioma (TSM) is an uncommon tumor among all intracranial meningiomas. As these tumors grow, they compress the surrounding structures, including the optic nerves and the pituitary gland. Ocular motor nerve palsy (OMNP) can occur as an isolated mononeuropathy or as part of multiple cranial nerve palsies. The role of corticosteroids in the management of OMNP has not been fully studied in the literature. In this report, we present a case of a previously well middle-aged woman who presented with severe headache and isolated OMNP on examination. MRI of the brain showed a small TSM that extends into the right optic canal. In our case, we noted the expedient and complete recovery of isolated OMNP within a few days following treatment with dexamethasone. This case report is on an isolated OMNP associated with TSM, which has not been previously reported. In addition, it highlights the role of corticosteroids in achieving rapid recovery from OMNP.

鞍座结核脑膜瘤是颅内脑膜瘤中一种少见的肿瘤。随着这些肿瘤的生长,它们会压迫周围的结构,包括视神经和脑垂体。眼运动神经麻痹(OMNP)可以作为孤立的单神经病变或作为多发性脑神经麻痹的一部分发生。皮质类固醇在OMNP管理中的作用尚未在文献中得到充分研究。在这个报告中,我们提出了一个病例,以前良好的中年妇女谁提出了严重的头痛和孤立的OMNP检查。脑MRI示小TSM延伸至右侧视神经管。在我们的病例中,我们注意到在地塞米松治疗后的几天内,分离的OMNP的方便和完全恢复。本病例报告是关于一个与TSM相关的孤立OMNP,以前没有报道过。此外,它强调了皮质类固醇在实现OMNP快速恢复中的作用。
{"title":"Isolated third cranial nerve palsy as the presenting sign of tuberculum sellae meningioma: a case report.","authors":"Azizah Alotaibi, Fay Althunayyan, Shuroq Alshehri, Hosam Al-Jehani","doi":"10.3389/fopht.2025.1525183","DOIUrl":"https://doi.org/10.3389/fopht.2025.1525183","url":null,"abstract":"<p><p>Tuberculum sellae meningioma (TSM) is an uncommon tumor among all intracranial meningiomas. As these tumors grow, they compress the surrounding structures, including the optic nerves and the pituitary gland. Ocular motor nerve palsy (OMNP) can occur as an isolated mononeuropathy or as part of multiple cranial nerve palsies. The role of corticosteroids in the management of OMNP has not been fully studied in the literature. In this report, we present a case of a previously well middle-aged woman who presented with severe headache and isolated OMNP on examination. MRI of the brain showed a small TSM that extends into the right optic canal. In our case, we noted the expedient and complete recovery of isolated OMNP within a few days following treatment with dexamethasone. This case report is on an isolated OMNP associated with TSM, which has not been previously reported. In addition, it highlights the role of corticosteroids in achieving rapid recovery from OMNP.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1525183"},"PeriodicalIF":0.0,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144082519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1